Cargando…
Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia
SIMPLE SUMMARY: Despite recent, rapid drug development success for patients with acute myeloid leukemia, distinct molecular and genetic aberrations still confer a poor prognosis. In this review, we explore the preclinical and early clinical development of two promising approaches: disrupting menin s...
Autores principales: | Matthews, Andrew H., Pratz, Keith W., Carroll, Martin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735817/ https://www.ncbi.nlm.nih.gov/pubmed/36497385 http://dx.doi.org/10.3390/cancers14235906 |
Ejemplares similares
-
Recent advances in targeted therapies in acute myeloid leukemia
por: Bhansali, Rahul S., et al.
Publicado: (2023) -
CD47 expression in acute myeloid leukemia varies according to genotype
por: Marra, Andrea, et al.
Publicado: (2023) -
Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023) -
Harnessing Macrophages through the Blockage of CD47: Implications for Acute Myeloid Leukemia
por: Melo Garcia, Luciana, et al.
Publicado: (2021) -
Addressing unmet needs in the treatment of COPD
por: Patalano, Francesco, et al.
Publicado: (2014)